In this issue:
CARTITUDE-1: Cilta-cel may be curative in some patients
Cytotoxic bridging before CAR T-cell therapy impairs hematopoietic recovery
Extramedullary disease portends inferior outcomes after CAR T-cell therapy
Outpatient administration of bispecific antibodies feasible for select patients
Early identification of functional high-risk multiple myeloma patients after transplant
Focal lesions in the long bones linked to poor outcomes
CT-MS is a promising tool for blood-based MRD monitoring
IMROZ: Isatuximab-combo efficacious regardless of frailty
Single-agent modakafusp alfa efficacious for RRMM
Long-term ReLApsE results do not support salvage transplant at first relapse
Please login below to download this issue (PDF)